Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100

Stryker Corporation (SYK) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Stryker Corporation (SYK) trades at a EV/FCF of 26.5×. Over the past ten years it has ranged from 18.6× (November 2016) to 301× (October 2017); the current reading is higher than 9% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 34.1× (18.69%)
FY2024 42.0× 7.49%
FY2023 39.0× (23.72%)
FY2022 51.2× 27.03%
FY2021 40.3× 9.12%
FY2020 36.9× (33.18%)
FY2019 55.2× 73.74%
FY2018 31.8× (51.87%)
FY2017 66.1× 95.27%
FY2016 33.8× (31.12%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 28.1× (6.58%)
Mar 2026 30.1× (11.76%)
Dec 2025 34.1× (6.51%)
Sep 2025 36.5× (11.20%)
42 more quarters

Against its own ten years

Low 18.6× High 301×
Ten-year median 42.5×
Current reading's percentile 3

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on SYK